Grants per year
Search results
-
Active
SMOF-018-CP3: A Prospective, Randomized, Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants Requiring 28 Days of Parent
Robinson MD MSc, D. T. (PD/PI)
Fresenius Kabi Deutschland GmbH
4/1/16 → 8/31/50
Project: Research project